Key result
CDH13 rs11859453 A allele is linked to ~75% lower repeat revascularization risk versus G carriers.
Why the study?
Repeat revascularization due to restenosis and disease progression is a major drawback of PCI, creating a need for genetic indicators to predict risk.
Do CDH13/CDH15 gene polymorphisms predict the risk of repeat revascularization in patients after first percutaneous coronary intervention?
Observational (n=143)
Do CDH13/CDH15 gene polymorphisms predict the risk of repeat revascularization in patients after first percutaneous coronary intervention?
Genetic variants in CDH13 and CDH15 may serve as biomarkers to predict the risk of repeat revascularization after percutaneous coronary intervention.
Answers are grounded in this paper and cite their sources.
CDH13 rs11859453 A allele may aid post-PCI revascularization risk stratification; leaves open prospective validation before clinical adoption.
Aim: Major drawbacks of percutaneous coronary intervention are the high occurrence of repeat revascularization due to restenosis and disease progression. The aim of this study was to find genetic indicators to predict the risk of repeat revascularization. Materials & methods: From April 2015 to June 2016, 143 patients with percutaneous coronary intervention with genetic test results were enrolled. SNPs were measured by OmniZhongHua-8, and the SNPs in pathways genes related to known stenosis-related processes from the KEGG, BioCarta and Gene Cards databases were selected for analysis. Results: Cell–extracellular matrix interactions were the pathways with the most significant SNP (CDH15 rs72819363) association with repeat revascularization. Compared with CDH13 rs11859453G carriers, the adjusted odds ratio for A carriers was 0.25 and 0.33 at 18 and 30 months. Conclusion: We demonstrated a potential role of the cell–extracellular matrix interactions pathway and the possible biomarker CDH13/CDH15 in the development of coronary repeat revascularization.
No takes yet. Share an insight, caveat, or question.
Xiang et al. (2019) conducted an observational in Percutaneous coronary intervention (n=143). CDH13 rs11859453 A allele carrier status vs. CDH13 rs11859453G carriers was evaluated on Repeat revascularization (OR 0.25). Carrying the CDH13 rs11859453 A allele was associated with a reduced risk of repeat revascularization compared to G carriers at 18 months and 30 months.
Synapse has enriched 10 related papers. Consider them for comparative context: